Walter Bardenheuer
- Oncology top 10%
- Cancer-related Molecular Pathways 4
-
- CRISPR and Genetic Engineering 6
- Epigenetics and DNA Methylation 4
- Genetics top 10%
- Genomic variations and chromosomal abnormalities 6
- Virus-based gene therapy research 5
-
- Cancer Genomics and Diagnostics 3
- Insect Science top 10%
- Bee Products Chemical Analysis 4
-
- Hematopoietic Stem Cell Transplantation 3
- Co-authors
- Ulrich R. HenggeDavid Díaz-CarballoS. SeeberBertram OpalkaAndrea TannapfelH. Peter ReuschJ. SchütteTassilo Moritz
- Cited by
- OncologyMolecular BiologyGenetics
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Walter Bardenheuer
37 papers receiving 831 citations
Peers
Comparison fields: 5 of 75
- Oncology 292
- Molecular Biology 509
- Genetics 192
- Cancer Research 99
- Insect Science 73
Countries citing papers authored by Walter Bardenheuer
This map shows the geographic impact of Walter Bardenheuer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Bardenheuer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Bardenheuer more than expected).
Fields of papers citing papers by Walter Bardenheuer
This network shows the impact of papers produced by Walter Bardenheuer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Bardenheuer. The network helps show where Walter Bardenheuer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Walter Bardenheuer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 20 | |
| 2 | 2013 | 3 | |
| 3 | 2012 | 16 | |
| 4 | 2010 | 21 | |
| 5 | 2008 | 11 | |
| 6 | 2008 | 47 | |
| 7 | 2008 | 29 | |
| 8 | 2006 | 57 | |
| 9 | 2005 | 156 | |
| 10 | 2004 | 13 | |
| 11 | 2004 | 7 | |
| 12 | 2003 | 14 | |
| 13 | 2001 | 25 | |
| 14 | Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression. | 2000 | 38 |
| 15 | 2000 | 25 | |
| 16 | 1999 | 12 | |
| 17 | 1998 | 21 | |
| 18 | 1996 | 15 | |
| 19 | 1996 | 7 | |
| 20 | 1993 | 22 |
About Walter Bardenheuer
Walter Bardenheuer is a scholar working on Genetics, Molecular Biology and Hematology, having authored 37 papers that have together received 848 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (6 papers), Genomic variations and chromosomal abnormalities (6 papers), Virus-based gene therapy research (5 papers), Bee Products Chemical Analysis (4 papers), Cancer-related Molecular Pathways (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer Genomics and Diagnostics (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Oncology (292 citations), Molecular Biology (509 citations) and Genetics (192 citations). Walter Bardenheuer has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Ulrich R. Hengge, David Díaz-Carballo, S. Seeber, Bertram Opalka, Andrea Tannapfel, H. Peter Reusch, J. Schütte, Tassilo Moritz, Michael Flaßhove and Iris Tischoff. Their work appears in journals such as Blood, JNCI Journal of the National Cancer Institute and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.